| |
| |
|
| Insider
Information: |
Oncology Impact Fund (cayman) Management L.p. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
4,484,728 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,484,728 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iteos Therapeutics, Inc. |
ITOS |
10% Owner |
2020-07-28 |
0 |
2022-01-05 |
4,484,728 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-07 |
4 |
AS |
$29.18 |
$1,488,063 |
I/I |
(50,996) |
5,953,372 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-07 |
4 |
AS |
$0.00 |
$0 |
I/I |
(31,340) |
5,922,032 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-08 |
4 |
AS |
$28.61 |
$579,723 |
I/I |
(20,236) |
5,901,796 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-09 |
4 |
AS |
$28.97 |
$1,101,671 |
I/I |
(38,028) |
5,863,768 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-10 |
4 |
AS |
$27.86 |
$640,691 |
I/I |
(22,643) |
5,841,125 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-13 |
4 |
AS |
$27.64 |
$989,097 |
I/I |
(35,785) |
5,805,340 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-14 |
4 |
AS |
$27.50 |
$995,198 |
I/I |
(36,081) |
5,769,259 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-15 |
4 |
AS |
$27.79 |
$1,121,535 |
I/I |
(40,336) |
5,728,923 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-16 |
4 |
AS |
$28.47 |
$1,012,536 |
I/I |
(35,565) |
5,693,358 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-17 |
4 |
AS |
$28.82 |
$2,203,952 |
I/I |
(76,473) |
5,616,885 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-20 |
4 |
AS |
$27.03 |
$1,117,964 |
I/I |
(40,673) |
5,576,212 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-21 |
4 |
AS |
$27.47 |
$902,609 |
I/I |
(32,858) |
5,543,354 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-22 |
4 |
AS |
$27.54 |
$658,784 |
I/I |
(23,921) |
5,519,433 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-23 |
4 |
AS |
$27.96 |
$1,728,432 |
I/I |
(61,800) |
5,457,633 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-24 |
4 |
AS |
$27.81 |
$228,626 |
I/I |
(8,221) |
5,449,412 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-27 |
4 |
AS |
$27.09 |
$527,036 |
I/I |
(19,455) |
5,429,957 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-28 |
4 |
AS |
$27.00 |
$868,158 |
I/I |
(32,154) |
5,397,803 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-30 |
4 |
AS |
$27.00 |
$103,572 |
I/I |
(3,836) |
5,393,967 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-01 |
4 |
AS |
$27.00 |
$309,717 |
I/I |
(11,471) |
5,382,496 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-04 |
4 |
AS |
$27.06 |
$937,873 |
I/I |
(34,659) |
5,347,837 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-07 |
4 |
AS |
$27.00 |
$51,894 |
I/I |
(1,922) |
5,345,915 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-08 |
4 |
AS |
$27.01 |
$91,834 |
I/I |
(3,400) |
5,342,515 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-11 |
4 |
AS |
$27.24 |
$2,225,072 |
I/I |
(81,684) |
5,260,831 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-12 |
4 |
AS |
$27.09 |
$386,303 |
I/I |
(14,260) |
5,246,571 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-13 |
4 |
AS |
$27.13 |
$950,174 |
I/I |
(35,023) |
5,211,548 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
